120 related articles for article (PubMed ID: 26646522)
1. DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.
Jajamovich GH; Huang W; Besa C; Li X; Afzal A; Dyvorne HA; Taouli B
MAGMA; 2016 Feb; 29(1):49-58. PubMed ID: 26646522
[TBL] [Abstract][Full Text] [Related]
2. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.
Hectors SJ; Wagner M; Besa C; Huang W; Taouli B
Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045
[TBL] [Abstract][Full Text] [Related]
4. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level.
Weiss J; Ruff C; Grosse U; Grözinger G; Horger M; Nikolaou K; Gatidis S
Invest Radiol; 2019 Dec; 54(12):737-743. PubMed ID: 31206392
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
[TBL] [Abstract][Full Text] [Related]
8. Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.
Tudorica A; Oh KY; Chui SY; Roy N; Troxell ML; Naik A; Kemmer KA; Chen Y; Holtorf ML; Afzal A; Springer CS; Li X; Huang W
Transl Oncol; 2016 Feb; 9(1):8-17. PubMed ID: 26947876
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.
Zhang W; Chen HJ; Wang ZJ; Huang W; Zhang LJ
Eur Radiol; 2017 May; 27(5):2086-2094. PubMed ID: 27488851
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation.
Lin CC; Cheng YF; Chiang HJ; Lazo M; Chang CD; Tsang LL; Yu CY; Hsu HW; Chen WT; Wang CC; Liang JL; Eng HL; Chen CL; Ou HY
Transplant Proc; 2016 May; 48(4):1041-4. PubMed ID: 27320551
[TBL] [Abstract][Full Text] [Related]
11. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
[TBL] [Abstract][Full Text] [Related]
12. Validation of Interstitial Fractional Volume Quantification by Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscles.
Hindel S; Söhner A; Maa M; Sauerwein W; Baba HA; Kramer M; Lüdemann L
Invest Radiol; 2017 Jan; 52(1):66-73. PubMed ID: 27482651
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.
Taouli B; Johnson RS; Hajdu CH; Oei MT; Merad M; Yee H; Rusinek H
AJR Am J Roentgenol; 2013 Oct; 201(4):795-800. PubMed ID: 24059368
[TBL] [Abstract][Full Text] [Related]
15. Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.
Inglese M; Ordidge KL; Honeyfield L; Barwick TD; Aboagye EO; Waldman AD; Grech-Sollars M
Neuroradiology; 2019 Dec; 61(12):1375-1386. PubMed ID: 31392385
[TBL] [Abstract][Full Text] [Related]
16. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma: A Pilot Comparative Study.
Lee SH; Hayano K; Zhu AX; Sahani DV; Yoshida H
Acad Radiol; 2015 Nov; 22(11):1344-60. PubMed ID: 26211553
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.
Joo I; Lee JM; Han JK; Yang HK; Lee HJ; Choi BI
J Magn Reson Imaging; 2015 Jun; 41(6):1608-14. PubMed ID: 25044978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
